Next 10 |
Q1 2024 revenues were $5.8 million, up 53% from Q1 2023 Q1 2024 gross margin was 73%, up 600bp from Q1 2023 Operating loss was $1.1 million for Q1 2024 compared to $2.0 million for Q1 2023 Company provides guidance for revenue growth of 45-55% for Q2 2024 versus Q2 2023 and reit...
EDEN PRAIRIE, MN - ( NewMediaWire ) - May 07, 2024 - SANUWAVE Health, Inc. (the "Company" or "Sanuwave”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, May 10, 2024, at 8:30 AM (ET) to present the Q1 2024 f...
SANUWAVE is pleased to announce preliminary revenues of $5.7 million to $5.9 million for the first quarter ended March 31, 2024. This represents the highest Q1 revenues in company history. Q1 2024 revenue increased between 51% and 56% compared to Q1 2023. UltraMist revenues for Q1 2...
Sorensen brings strong finance, forecasting, analysis, and capital markets experience as well as abilities in software, process automation, and human resources to SANUWAVE EDEN PRAIRIE, MN - ( NewMediaWire ) - April 01, 2024 - SANUWAVE Health, Inc. (the "Company" or "SANUWAVE...
2024-04-01 16:05:01 ET More on SANUWAVE Health SANUWAVE Health Inc. (SNWV) Q4 2023 Earnings Call Transcript SEP Acquisition shareholders approve Sanuwave SPAC merger Sanuwave Health sees Q4 record revenue $6.6M-$6.8M, up 20% Y/Y Financial information for SANU...
2024-03-22 13:17:11 ET SANUWAVE Health Inc. (SNWV) Q4 2023 Results Conference Call March 22, 2024 8:30 AM ET Company Participants Morgan Frank - CEO & Chairman Toni Rinow - Chief Financial Officer Conference Call Participants Candace Laryea - MD Catas...
2024-03-22 07:26:07 ET More on SANUWAVE Health SEP Acquisition shareholders approve Sanuwave SPAC merger Sanuwave Health sees Q4 record revenue $6.6M-$6.8M, up 20% Y/Y Financial information for SANUWAVE Health Read the full article on Seeking Alpha Fo...
Q4 2023 revenues were a record $7.0 million, up 27% from Q4 2022 FY 2023 revenues were a record $20.4 million, up 22% from FY2022 Operating income was $1 million for Q4 2023 compared to an operating loss of $1.5 million for Q4 2022 Company provides guidance for revenue g...
Sanuwave Health Inc (SNWV) is expected to report for quarter end 2023-12-31
EDEN PRAIRIE, MN - ( NewMediaWire ) - March 20, 2024 - SANUWAVE Health, Inc. (the "Company" or "Sanuwave”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, March 22, 2024, at 8:30 AM (ET) to pre...
News, Short Squeeze, Breakout and More Instantly...
Sanuwave Health Inc Company Name:
SNWV Stock Symbol:
OTCMKTS Market:
Q1 2024 revenues were $5.8 million, up 53% from Q1 2023 Q1 2024 gross margin was 73%, up 600bp from Q1 2023 Operating loss was $1.1 million for Q1 2024 compared to $2.0 million for Q1 2023 Company provides guidance for revenue growth of 45-55% for Q2 2024 versus Q2 2023 and reit...
EDEN PRAIRIE, MN - ( NewMediaWire ) - May 07, 2024 - SANUWAVE Health, Inc. (the "Company" or "Sanuwave”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, May 10, 2024, at 8:30 AM (ET) to present the Q1 2024 f...
SANUWAVE is pleased to announce preliminary revenues of $5.7 million to $5.9 million for the first quarter ended March 31, 2024. This represents the highest Q1 revenues in company history. Q1 2024 revenue increased between 51% and 56% compared to Q1 2023. UltraMist revenues for Q1 2...